Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Citi
UBS
AstraZeneca
Deloitte
McKesson
Chubb
Farmers Insurance
Harvard Business School

Generated: October 21, 2018

DrugPatentWatch Database Preview

ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE - Generic Drug Details

« Back to Dashboard

What are the generic sources for acetaminophen; propoxyphene napsylate and what is the scope of acetaminophen; propoxyphene napsylate patent protection?

Acetaminophen; propoxyphene napsylate is the generic ingredient in five branded drugs marketed by Xanodyne Pharm, Teva, Able, Actavis Elizabeth, Cornerstone, Halsey, Ivax Sub Teva Pharms, Mallinckrodt, Mirror Pharms, Mutual Pharm, Mylan, Mylan Pharms Inc, Sandoz, Superpharm, Vintage Pharms, Watson Labs, Watson Labs Florida, and Wockhardt Ltd, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-six drug master file entries for acetaminophen; propoxyphene napsylate.

Summary for ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE
US Patents:0
Tradenames:5
Applicants:18
NDAs:29
Drug Master File Entries: 66
DailyMed Link:ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE at DailyMed

US Patents and Regulatory Information for ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xanodyne Pharm DARVOCET-N 50 acetaminophen; propoxyphene napsylate TABLET;ORAL 017122-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Xanodyne Pharm DARVOCET-N 100 acetaminophen; propoxyphene napsylate TABLET;ORAL 017122-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vintage Pharms PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN acetaminophen; propoxyphene napsylate TABLET;ORAL 074843-002 Feb 15, 2001 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mutual Pharm PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN acetaminophen; propoxyphene napsylate TABLET;ORAL 070771-001 Mar 21, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Citi
UBS
AstraZeneca
Deloitte
McKesson
Chubb
Farmers Insurance
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.